Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Off-Label Use of Atypical Antipsychotics: An Update

Slide: 9 of 47

Clinical Questions Addressed by the Comparative Effectiveness Review (1 of 2)

The comparative effectiveness review addressed several key clinical questions, including: What are the leading off-label uses of atypical antipsychotics in utilization studies? How have trends in utilization changed in recent years, including inpatient versus outpatient use? What new uses are being studied in trials? What does the evidence show regarding the efficacy and comparative effectiveness of atypical antipsychotics for off-label indications? How do atypical antipsychotic medications compare with other drugs, including first-generation antipsychotics, for treating off-label indications?